Industry News
Second-Line Defense Needed For Patients With NSCLC
Jul 26, 2012
In lung cancer, patients who benefit from drugs like erlotinib will inevitably develop drug resistance. This is heralded by cancer growth and increasing tumor-related symptoms. Now scientists are investigating a second line of defense by studying the use of the novel AKT inhibitor MK-2206 in combination with erlotinib for patients whose benefit from erlotinib has begun to wane... Read More
Second-Line Defense Needed For Patients With NSCLC
Jul 26, 2012
In lung cancer, patients who benefit from drugs like erlotinib will inevitably develop drug resistance. This is heralded by cancer growth and increasing tumor-related symptoms. Now scientists are investigating a second line of defense by studying the use of the novel AKT inhibitor MK-2206 in combination with erlotinib for patients whose benefit from erlotinib has begun to wane... Read More
Potential To Improve Human Cancer Studies Using Novel Pig Model
Jul 26, 2012
A naturally occurring line of immunodeficient pigs can support the growth of human tumors injected under their skin, offering a promising new large animal model for studying human cancers and testing new drugs and treatment strategies... Read More
Potential To Improve Human Cancer Studies Using Novel Pig Model
Jul 26, 2012
A naturally occurring line of immunodeficient pigs can support the growth of human tumors injected under their skin, offering a promising new large animal model for studying human cancers and testing new drugs and treatment strategies... Read More
Chronic Obstructive Pulmonary Disease And Increased Risk Of Lung Cancer
Jul 26, 2012
In addition to the well-known risk factor of smoking, chronic obstructive pulmonary disease (COPD) increases lung cancer risk. A University of Colorado Cancer Center study published in the journal Cancer Prevention Research details one novel mechanism of this risk: long-term oxygen depletion stimulates signals that promote tumor growth... Read More
Chronic Obstructive Pulmonary Disease And Increased Risk Of Lung Cancer
Jul 26, 2012
In addition to the well-known risk factor of smoking, chronic obstructive pulmonary disease (COPD) increases lung cancer risk. A University of Colorado Cancer Center study published in the journal Cancer Prevention Research details one novel mechanism of this risk: long-term oxygen depletion stimulates signals that promote tumor growth... Read More
Following Large-scale HPV Vaccination, Human Papillomavirus Types Do Not Replace Others
Jul 26, 2012
Vaccines against human papillomavirus (HPV) are now recommended by the Centers for Disease Control and Prevention for both teenage boys and girls. The vaccine protects against the two most common types of the virus that cause cervical cancer: HPV 16 and 18... Read More
New Probe Helps Find Cancerous Brain Tumors
Jul 26, 2012
Performing surgery to remove a brain tumor requires surgeons to walk a very fine line. If they leave tumor tissue behind, the tumor is likely to regrow; if they cut out too much normal tissue, they could cause permanent brain damage... Read More
Driver Of Breast Cancer Stem Cell Metastasis Discovered
Jul 26, 2012
Researchers at the University of Michigan Comprehensive Cancer Center have found that a cancer gene linked to aggressive spread of the disease promotes breast cancer stem cells. The finding implies a new way to target the behavior of these lethal cells. The finding involves the cancer gene RhoC, which has previously been shown to promote metastasis of many types of cancer... Read More
Sudden Cardiac Death In Black Athletes May Be Caused By Sickle Cell Trait
Jul 26, 2012
While some published research has hinted at the connection between the sickle cell trait and sudden cardiac death among young, athletic African-American males, which was initially observed in black military recruits 25 years ago, a new study with the first sizeable patient series definitively confirms this risk for these individuals during competitive sports... Read More
Previous Page Next Page